Source: Health Products Regulatory Authority (ZA) Revision Year: 2021 Publisher: LeBasi Pharmaceuticals (Pty) Ltd, San Domenico Building, Unit 6, Ground Floor, 10 Church Street, Durbanville, 7551
Ketesse 25 mg film coated tablets.
| Pharmaceutical Form |
|---|
|
Film coated tablets. Ketesse 25 mg: White film coated tablets, scored on both sides, with convex sides. The tablets can be divided into equal doses. |
Each tablet contains: dexketoprofen 25 mg (as dexketoprofen trometamol).
Sugar free.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Dexketoprofen |
Dexketoprofen belongs to the non-steroidal anti-inflammatory group of drugs. The mechanism of action of Dexketoprofen is related to the reduction of prostaglandin synthesis by the inhibition of cyclooxygenase pathway. Furthermore, the inhibition of the synthesis of prostaglandins could affect other inflammation mediators such as kinins, causing an indirect action which would be additional to the direct action. |
| List of Excipients |
|---|
|
Maize starch |
Opaque white or transparent PVC/aluminium or aluminium/aluminium blister strips in an outer carton.
Pack sizes: 4, 10, 20, 30, 50 or 500 film coated tablets.
Not all pack sizes may be marketed.
LeBasi Pharmaceuticals (Pty) Ltd, San Domenico Building, Unit 6, Ground Floor, 10 Church Street, Durbanville, 7551
54/2.7/0536
27 July 2021
| Drug | Countries | |
|---|---|---|
| KETESSE | Austria, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Lithuania, Nigeria, Poland, Singapore, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
